<DOC>
	<DOCNO>NCT00077792</DOCNO>
	<brief_summary>The primary objective study determine whether enoxaparin compare unfractionated heparin reduce composite endpoint all-cause mortality non-fatal myocardial re-infarction within 30 day randomization patient acute ST-segment elevation myocardial infarction eligible receive fibrinolytic therapy</brief_summary>
	<brief_title>Enoxaparin Thrombolysis Reperfusion Acute Myocardial Infarction Treatment Thrombolysis Myocardial Infarction - Study 25 ( ExTRACT-TIMI25 )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients STsegment elevation acute myocardial infarction meeting follow criterion : Male nonpregnant female great equal 18 year age ( depend local regulation , minimal age vary 18 21 year ) Onset prolong ( great equal 20 min ) ischemic symptom rest less equal 6 hour prior randomization STsegment elevation 0.1 mV 2 limb lead , 0.2 mV two ( 2 ) contiguous precordial lead , leave bundlebranch block Planned reperfusion therapy streptokinase , tenecteplase , alteplase reteplase Written inform consent obtain EXCLUSION CRITERIA : Cardiovascular Evidence cardiogenic shock randomization Acute pericarditis History symptom suggestive aortic dissection MI precipitate obvious provoke factor arrhythmia , infection , severe anemia , hyperthyroidism , cocaine , amphetamine Hemorrhagic Risk Any minor head trauma trauma occur index acute myocardial infarction Active recent ( &lt; 3 month ) bleed include gastrointestinal bleeding , know presence occult blood stool , gross hematuria . Any history bleeding diathesis , coagulopathy , platelet disorder , thrombocytopenia Any single reliable record systolic blood pressure &gt; 180 mm Hg and/or diastolic blood pressure &gt; 110 mm Hg prior randomization Any history stroke transient ischemic attack ; history hemorrhagic cerebrovascular disease Any known structural damage pathologic process involve central nervous system Any head trauma within 6 month prior randomization Major surgery ( include CABG ) , ophthalmologic surgery , noncutaneous biopsy , substantial trauma within 3 month prior randomization Traumatic prolong cardiopulmonary resuscitation ( &gt; 2 minute ) within 2 week prior randomization Puncture noncompressible vessel ( artery vein ) within 24 hour prior randomization Acute peptic ulcer disease within 3 month prior randomization Prior Concomitant Pharmacologic Therapy Administration abciximab ( ReoPro ) , within previous 7 day eptifibatide ( Integrilin ) , tirofiban ( Aggrastat ) within previous 24 hour prior randomization Current therapy oral anticoagulant , International Normalized Ratio &gt; 1.5 Administration low molecular weight heparin within 8 hour prior randomization . Known hypersensitivity low molecular weight heparin , unfractionated heparin heparinlike product ; allergy pork pork product Known hypersensitivity and/or contraindication ( ) fibrinolytic drug ( streptokinase , tenecteplase , alteplase reteplase ) General Known platelet count &lt; 100,000 cells/microL history heparininduced thrombocytopenia Known clinically significant anemia ( Hemoglobin &lt; 10 g/dL &lt; 6.2 mmol/L ) Known renal insufficiency serum creatinine &gt; 220 mmol/L ( 2.5 mg/dL ) men &gt; 175 mmol/L ( 2.0 mg/dL ) woman assess prior baseline examination . Advanced neoplastic lifethreatening disease life expectancy &lt; 12 month Pregnancy parturition within last 90 day currently breast feed Women childbearing potential except postmenopausal , surgically sterile use accepted method ( ) birth control negative pregnancy test . Treatment investigational agent last 30 day study entry previous enrollment ExTRACTTIMI 25 History drug alcohol abuse Mental condition render patient unable understand nature , scope , possible consequence study Any patient unlikely comply protocol , e.g. , uncooperative attitude , inability return followup visit , unlikely complete study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Receiving fibrinolytic therapy</keyword>
</DOC>